About This Calculator

The Naloxone Bolus plus Infusion Calculator is designed to assist healthcare professionals in determining appropriate dosing for the reversal of opioid toxicity. It calculates an initial intravenous (IV) bolus dose based on patient weight and provides parameters for a subsequent continuous IV infusion to prevent recurrent respiratory depression, particularly after exposure to long-acting opioids.

Outputs Explained

After entering the required patient and drug information, the calculator provides the following key outputs for clinical use:

• Initial Bolus Dose (mg): The total mass of naloxone to be administered as a single IV push, calculated from the patient's weight and the specified mg/kg dose.
• Volume to Administer (mL): The volume of the naloxone solution required to deliver the calculated bolus dose, based on the specified drug concentration.
• Final IV Concentration (mg/mL & mcg/mL): The concentration of the prepared naloxone infusion bag, determined by the amount of naloxone added and the total IV fluid volume.
• Infusion Pump Rate (mL/hour): The final rate at which the infusion pump should be set to deliver the required hourly dose. This is the primary actionable output for initiating the continuous infusion.

How to Use

To ensure accurate calculations, follow these steps for data entry:

1. Patient Weight: Enter the patient's weight and select the appropriate unit (kg or lbs). The tool will automatically convert lbs to kg for calculations.
2. Bolus Dose (mg/kg): Input the desired weight-based dose for the initial reversal. This is often titrated, starting low (e.g., 0.01 mg/kg) to reverse respiratory depression while avoiding severe withdrawal.
3. Naloxone Concentration: Select the concentration of the naloxone vial being used (e.g., 0.4 mg/mL or 1 mg/mL) or enter a custom value.
4. Effective Bolus Dose (mg): Enter the total cumulative bolus dose that was required to achieve the desired clinical effect (e.g., adequate spontaneous respiration). This value is the basis for the infusion calculation.
5. Infusion Rate Rule (%): This is the percentage of the effective bolus dose to be administered each hour. The default of 67% corresponds to the common "two-thirds rule."
6. Naloxone to Add (mg): Input the total amount of naloxone to be added to the IV fluid bag for the infusion.
7. IV Fluid Bag Volume (mL): Select the total volume of the IV fluid bag (e.g., 250 mL, 500 mL) or enter a custom volume.

Dosing Overview

The primary goal of naloxone administration is to restore adequate spontaneous ventilation without precipitating acute, severe opioid withdrawal. A continuous infusion is indicated when there is a high risk of recurrent toxicity, such as with long-acting opioids (methadone, buprenorphine) or in large overdoses.

The "two-thirds rule" is a widely cited heuristic for starting a naloxone infusion. It recommends an hourly infusion rate equal to two-thirds (approx. 67%) of the initial bolus dose that successfully reversed the patient's symptoms. The infusion rate should always be titrated up or down based on the patient's clinical response, including respiratory rate, oxygen saturation, and level of consciousness.

Switching from Bolus to Infusion

The transition from intermittent bolus dosing to a continuous infusion is a critical step in managing significant opioid overdose. This switch is warranted after a patient has responded to an initial bolus (or multiple boluses) but is deemed at risk for re-sedation as the naloxone wears off. The total effective bolus dose is used to calculate a steady-state infusion that maintains naloxone's therapeutic effect, providing a more stable clinical course than repeated IV pushes.

Managing Recurrent Toxicity

In the context of a naloxone infusion, a "missed dose" is not applicable. Instead, the concern is a worsening of the patient's condition despite the infusion. If signs of recurrent opioid toxicity (e.g., bradypnea, sedation) reappear, the patient should be given a supplemental bolus of naloxone (often 50-100% of the initial effective dose) and the infusion rate should be increased, typically by 25-50%. Continuous reassessment is essential.

Safety Alerts

• Opioid Withdrawal: Administering naloxone, especially at high doses, can precipitate severe acute opioid withdrawal in dependent individuals. This can cause agitation, nausea, vomiting, and cardiovascular stress. The goal is to use the lowest effective dose.
• Short Half-Life: Naloxone's duration of action (30-90 minutes) is shorter than that of most opioids. Patients must be monitored for several hours after the last dose, even if an infusion is not required.
• Titration to Effect: Dosing is not one-size-fits-all. All calculated doses are starting points. The infusion must be titrated to the patient's respiratory rate and level of consciousness.
• Clinical Judgment: This tool is for informational purposes only and is not a substitute for professional clinical judgment. Verify all calculations before administration.

Frequently Asked Questions

1. Why is the "two-thirds rule" (67%) used for the infusion rate?
It is a widely adopted clinical guideline that provides a starting infusion rate likely to maintain the therapeutic effect achieved by the initial bolus, while minimizing the risk of over-antagonism and withdrawal.

2. What should I do if the patient develops severe withdrawal symptoms?
If severe withdrawal occurs, the naloxone infusion should be stopped or significantly reduced. Symptomatic treatment for withdrawal (e.g., antiemetics, clonidine) may be necessary. The primary goal is restoring respiration, not complete opioid receptor blockade.

3. How long should a naloxone infusion be continued?
The duration depends on the half-life of the opioid involved. For long-acting opioids like methadone, infusions may be needed for 24-48 hours. The infusion can typically be weaned off when the patient has been stable for several hours without requiring additional boluses.

4. Can this calculator be used for pediatric patients?
While the principles of weight-based dosing apply, pediatric naloxone administration requires special consideration. Always consult pediatric-specific protocols and a pharmacist. Dosing and concentrations may differ significantly.

5. What are the most common naloxone concentrations supplied?
The most common concentrations for IV use are 0.4 mg/mL and 1 mg/mL, which are included as presets in the calculator.

6. Why is "Effective Bolus Dose" a separate input from the initial calculated bolus?
Often, a single calculated bolus is insufficient. A patient may require several doses to achieve adequate respiration. The "Effective Bolus Dose" is the total amount given to get the desired clinical response, which is the correct basis for the infusion calculation.

7. What if the patient's weight is an estimate?
If an exact weight is unavailable, use a careful estimate. Titrating to clinical effect is more important than the exact initial calculation. The infusion can be adjusted based on the patient's response regardless of the initial weight estimate.

8. What IV fluids are compatible with naloxone?
Naloxone is stable in 0.9% Sodium Chloride (Normal Saline) and 5% Dextrose in Water (D5W).